ProCE Banner Activity

Elevating the Science of HER3-Targeted Therapy to Improve Outcomes in Breast Cancer


This downloadable slideset developed by Yuan Yuan, MD, PhD, provides an overview of clinical data and ongoing trials of HER3-targeted agents in development for the treatment of patients with breast cancer, including patients with acquired resistance to other targeted therapies.

Released: October 13, 2023



Yuan Yuan

Yuan Yuan, MD, PhD

Director, Breast Oncology
Cedars-Sinai Medical Center
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.